National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
Summary
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)
Bill status
passed
3 of 5 stages cleared
Introduction
Jul 2021
Committee Review
Oct 2021
House Passage
Oct 2021
Senate Passage
President
Introduced Jul 6, 2021
Last action Oct 20, 2021
Floor votes · House Oct 19, 2021
How they voted
368–56
Passed · 7 other
Total votes 431
Oct 19, 2021
D
Democratic219
99% Yea
R
Republican212
71% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
19
Key actions
5
Committee
7
Amendments
4
Oct 20, 2021
Committee
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Oct 19, 2021
Introduced
The title of the measure was amended. Agreed to without objection.
lower
Oct 19, 2021
Introduced
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318). (text: CR H5645-5647)
lower
Oct 19, 2021
Lower · Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318).(text: CR H5645-5647)
lower
Oct 19, 2021
Introduced
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
lower
Oct 19, 2021
Lower · Passed
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-151.
lower
Jul 21, 2021
Introduced
Ordered to be Reported (Amended) by Voice Vote.
lower
Jul 21, 2021
Lower · Passed
Committee Consideration and Mark-up Session Held.
lower
Jul 15, 2021
Lower · Passed
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
lower
Jul 15, 2021
Lower · Passed
Subcommittee Consideration and Mark-up Session Held.
lower
Jul 7, 2021
Committee
Referred to the Subcommittee on Health.
lower
Jul 6, 2021
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jul 6, 2021
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 4369
Scope: US
Hi! I can help you understand HR 4369. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline